The Board of Directors of the Canadian Partnership Against Cancer is pleased to announce the appointment of Shelly Jamieson as CEO effective July 3, 2012.
“Ms. Jamieson’s appointment comes at an exciting time for Canada’s cancer control community. Working together over the past five years we have moved Canada’s cancer strategy forward significantly, engaging the The Canadian Strategy for Cancer Control as the blueprint for our shared efforts and focusing on priorities and initiatives with the greatest potential for impact,” said Dr. Simon Sutcliffe, Chair of the Partnership’s Board of Directors. “The recent publication of the Partnership’s 2012-17 strategic and business plan, together with today’s announcement of new leadership for the organization, builds on the accomplishments of the first mandate and begins the next phase of Canada’s cancer strategy.”
To the role of CEO, Ms. Jamieson brings strong executive experience in the public and private sectors, primarily in healthcare. Most recently, she held Ontario’s highest-ranking civil servant role as Secretary of Cabinet, Head of the Ontario Public Service and Clerk of the Executive Council. She also served as Deputy Minister of Transportation for the province of Ontario. Roles previously held by Ms. Jamieson include Vice-President of Operations and then President of Extendicare Canada, a provider of long-term care; volunteer commissioner on the Health Services Restructuring Commission; and Executive Director of the Ontario Nursing Home Association (now the Ontario Long-Term Care Association). In all of these roles, Ms. Jamieson has demonstrated a commitment to the importance of effective partnerships in achieving meaningful outcomes.
“Ms. Jamieson’s experience in the public and private sectors and her commitment to partnerships and results will serve us well as we build on achievements to date,” said Chris Clark, incoming Chair of the Canadian Partnership Against Cancer and Chair of the CEO Search Committee. “We look forward to continuing to work with our partners to advance Canada’s cancer strategy and reduce the burden of cancer on Canadians.”